Compare RNAZ & BRLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNAZ | BRLT |
|---|---|---|
| Founded | 2016 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9M | 24.6M |
| IPO Year | 2021 | 2021 |
| Metric | RNAZ | BRLT |
|---|---|---|
| Price | $1.77 | $1.52 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $1.59 |
| AVG Volume (30 Days) | 26.9K | ★ 50.6K |
| Earning Date | 08-14-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $437,483,000.00 |
| Revenue This Year | N/A | $5.18 |
| Revenue Next Year | N/A | $5.68 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.63 |
| 52 Week Low | $1.52 | $1.00 |
| 52 Week High | $13.92 | $2.90 |
| Indicator | RNAZ | BRLT |
|---|---|---|
| Relative Strength Index (RSI) | 47.56 | 62.05 |
| Support Level | $1.55 | $1.26 |
| Resistance Level | $1.93 | $1.64 |
| Average True Range (ATR) | 0.16 | 0.10 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 57.25 | 64.52 |
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
Brilliant Earth Group Inc is an digitally native omnichannel jewelry company selling The company's products include rings, necklaces, earrings, and bracelets. Its collection of premium-quality diamond engagement and wedding rings, gemstone rings, and fine jewelry is conceptualized by in-house design studio. The company operates in one operating and reporting segment, the retail sale of diamonds, gemstones and jewelry.